Pakistan Oxygen Past Earnings Performance
Past criteria checks 1/6
Pakistan Oxygen's earnings have been declining at an average annual rate of -3.8%, while the Chemicals industry saw earnings growing at 15.9% annually. Revenues have been growing at an average rate of 13.5% per year. Pakistan Oxygen's return on equity is 3.3%, and it has net margins of 3.1%.
Key information
-3.8%
Earnings growth rate
-5.0%
EPS growth rate
| Chemicals Industry Growth | 19.3% |
| Revenue growth rate | 13.5% |
| Return on equity | 3.3% |
| Net Margin | 3.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Pakistan Oxygen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 9,501 | 290 | 643 | 0 |
| 31 Dec 23 | 8,589 | 145 | 637 | 0 |
| 30 Sep 23 | 7,798 | 157 | 647 | 0 |
| 30 Jun 23 | 7,227 | 249 | 628 | 0 |
| 31 Mar 23 | 7,282 | 333 | 609 | 0 |
| 31 Dec 22 | 7,296 | 420 | 587 | 0 |
| 30 Sep 22 | 7,218 | 405 | 581 | 0 |
| 30 Jun 22 | 7,222 | 436 | 564 | 0 |
| 31 Mar 22 | 7,312 | 463 | 558 | 0 |
| 31 Dec 21 | 7,005 | 451 | 538 | 0 |
| 30 Sep 21 | 6,863 | 529 | 536 | 0 |
| 30 Jun 21 | 6,807 | 526 | 516 | 0 |
| 31 Mar 21 | 5,871 | 438 | 473 | 0 |
| 31 Dec 20 | 5,545 | 346 | 475 | 0 |
| 30 Sep 20 | 5,174 | 196 | 463 | 0 |
| 30 Jun 20 | 4,640 | 143 | 460 | 0 |
| 31 Mar 20 | 4,718 | 223 | 472 | 0 |
| 31 Dec 19 | 4,667 | 301 | 461 | 0 |
| 30 Sep 19 | 4,776 | 372 | 454 | 0 |
| 30 Jun 19 | 4,792 | 405 | 432 | 0 |
| 31 Mar 19 | 4,840 | 413 | 396 | 0 |
| 31 Dec 18 | 4,860 | 399 | 404 | 0 |
| 30 Sep 18 | 4,746 | 339 | 444 | 0 |
| 30 Jun 18 | 4,674 | 310 | 476 | 0 |
| 31 Mar 18 | 4,553 | 265 | 514 | 0 |
| 31 Dec 17 | 4,413 | 240 | 512 | 0 |
| 30 Sep 17 | 4,290 | 268 | 461 | 0 |
| 30 Jun 17 | 4,080 | 240 | 451 | 0 |
| 31 Mar 17 | 3,978 | 224 | 458 | 0 |
| 31 Dec 16 | 3,955 | 217 | 456 | 0 |
| 30 Sep 16 | 3,893 | 195 | 466 | 0 |
| 30 Jun 16 | 3,917 | 190 | 472 | 0 |
| 31 Mar 16 | 3,915 | 151 | 461 | 0 |
| 31 Dec 15 | 3,914 | 141 | 464 | 0 |
| 30 Sep 15 | 3,900 | 105 | 481 | 0 |
| 30 Jun 15 | 3,871 | 80 | 474 | 0 |
| 31 Mar 15 | 3,917 | 111 | 468 | 0 |
| 31 Dec 14 | 3,925 | 127 | 465 | 0 |
| 30 Sep 14 | 3,994 | 179 | 443 | 0 |
| 30 Jun 14 | 4,055 | 186 | 426 | 0 |
| 31 Mar 14 | 4,082 | 184 | 425 | 0 |
| 31 Dec 13 | 4,016 | 181 | 414 | 0 |
| 30 Sep 13 | 3,969 | 214 | 417 | 0 |
| 30 Jun 13 | 3,955 | 222 | 423 | 0 |
Quality Earnings: PAKOXY has high quality earnings.
Growing Profit Margin: PAKOXY's current net profit margins (3.1%) are lower than last year (4.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PAKOXY's earnings have declined by 3.8% per year over the past 5 years.
Accelerating Growth: PAKOXY's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PAKOXY had negative earnings growth (-13%) over the past year, making it difficult to compare to the Chemicals industry average (36.1%).
Return on Equity
High ROE: PAKOXY's Return on Equity (3.3%) is considered low.